More News

12 Jan 2021 La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe
12 Jan 2021 Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
11 Jan 2021 Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs
11 Jan 2021 Eligo Bioscience inks deal with GSK potentially worth up to $224 million
10 Jan 2021 Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
08 Jan 2021 Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
08 Jan 2021 Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies
07 Jan 2021 Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies
07 Jan 2021 Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
06 Jan 2021 Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
06 Jan 2021 Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
30 Dec 2020 Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
23 Dec 2020 Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties
23 Dec 2020 Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health
23 Dec 2020 ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company
22 Dec 2020 Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
22 Dec 2020 Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
22 Dec 2020 Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System
22 Dec 2020 Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
22 Dec 2020 Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
18 Dec 2020 Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
18 Dec 2020 Histogen Announces Filing an Investigational New Drug Application for HST-003
18 Dec 2020 ONK Therapeutics Announces Three Exclusive Option License Agreements, Which Extend and Strengthen its Dual-Targeted NK Cell Therapy Pipeline
18 Dec 2020 Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
18 Dec 2020 Leading BioSciences and Seneca Biopharma Announce Merger

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up